Globeflex Capital L P acquired a new stake in Envista Holdings Corporation (NYSE:NVST – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 31,232 shares of the company’s stock, valued at approximately $792,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP raised its holdings in shares of Envista by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock valued at $72,726,000 after purchasing an additional 444,725 shares during the last quarter. Millennium Management LLC boosted its holdings in Envista by 1,442.7% in the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock valued at $52,552,000 after purchasing an additional 2,263,712 shares during the last quarter. Finally, AQR Capital Management LLC grew its position in Envista by 72.3% during the 4th quarter. AQR Capital Management LLC now owns 2,356,968 shares of the company’s stock worth $51,170,000 after purchasing an additional 988,714 shares during the period.
Envista Stock Performance
Shares of NVST stock opened at $26.43 on Thursday. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The business’s 50 day moving average is $25.08 and its two-hundred day moving average is $25.71. The company has a market capitalization of $4.30 billion, a P/E ratio of 64.46, a P/E/G ratio of 1.53 and a beta of 0.86.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the company. Morgan Stanley lifted their price objective on Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. BMO Capital Markets assumed coverage on Envista in a report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 target price on the stock. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Citigroup initiated coverage on Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price target for the company. Finally, JPMorgan Chase & Co. boosted their price target on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $28.54.
Check Out Our Latest Stock Analysis on Envista
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Recommended Stories
- Five stocks we like better than Envista
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
